• ISBN13: 9780443273339
• Binding: Paperback
• Subject: N/A
• Publisher: Elsevier
• Publisher Imprint: Elsevier
• Publication Date: August 27, 2025
• Pages: 382
• Original Price: USD 175.0
• Language: English
• Edition: N/A
• Item Weight: 840 grams
• BISAC Subject(s): Life Sciences / Biophysics

Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer: From Bench to its Potential Therapeutics systematically summarizes findings concerning the biochemical properties of various reactive oxygen species (ROS). The book opens with foundational coverage of ROS, ROS signaling, as well as the role of ROS in controlling gene expression. Subsequent chapters cover molecular mechanisms of ROS, regulation of gene expression, and antioxidant supplementation with cardiometabolic syndrome, various neuronal diseases, and cancer. It concludes with recent findings on therapeutic modulations of intracellular levels of ROS, which may significantly impact the development of novel agents for treating the conditions covered.

This is a must-have reference for scientists and medical professionals seeking to enhance their knowledge of ROS research and the impact on treatments for cardiometabolic syndrome, neuronal diseases, and cancer.

Isenovic, Esma R.: - "

Esma R. Isenovic, PhD is a full professor/principal research fellow and Head of the Laboratory for Endocrinology, Hypertension, and Metabolic Diseases in the Department of Radiobiology and Molecular Genetics at the "VINA" Institute of Nuclear Sciences - National Institute of The Republic of Serbia, University of Belgrade, Serbia. Professor Isenovic's research interests over the last 25 years have been diabetes and cardiovascular diseases and the effects of various hormones on cardiovascular biology. She serves as an invited reviewer for 181 international scientific journals, on the Editorial Boards of 26 international scientific journals, and on the editorial boards of twelve international journals. Professor Isenovic has extensive experience in the international research program and proposal evaluation as an expert reviewer. She has published over 200 scientific papers in peer-reviewed journals and 24 book chapters.

Suri, Jasjit S.: -

Dr. Jasjit Suri, PhD, MBA, is a renowned innovator and scientist. He received the Director General's Gold Medal in 1980 and is a Fellow of several prestigious organizations, including the American Institute of Medical and Biological Engineering and the Institute of Electrical and Electronics Engineers. Dr. Suri has been honored with lifetime achievement awards from Marcus, NJ, USA, and Graphics Era University, India. He has published nearly 300 peer-reviewed AI articles, 100 books, and holds 100 innovations/trademarks, achieving an H-index of nearly 100 with about 43,000 citations. Dr. Suri has served as chairman of AtheroPoint, IEEE Denver section, and as an advisory board member to various healthcare industries and universities globally.